Occudo Quantitative Strategies LP Infla Rx N.V. Transaction History

Occudo Quantitative Strategies LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.35 - $5.58 $24,787 - $58,857	-10,548 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.25 - $3.03 $481 - $648	-214 Reduced 1.99%	10,548 $27,000
Q2 2021 Aug 16, 2021	SELL	$2.72 - $4.04 $856 - $1,272	-315 Reduced 2.84%	10,762 $32,000
Q1 2021 May 14, 2021	SELL	$3.62 - $6.34 $24,652 - $43,175	-6,810 Reduced 38.07%	11,077 $43,000
Q4 2020 Feb 16, 2021	BUY	$3.82 - $5.32 $68,328 - $95,158	17,887 New	17,887 $90,000

12.9M

19.3K

Ticker IFRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,203,800
Market Cap $99M
Description
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.